FDA PMA FDA Class 3 Approved 🇺🇸 United States

Stimulator, Neuromuscular, Lower Back Muscles, Totally Implanted For Pain Relief

PMA: P190021 · Supplement: S003 · Decision Jun 23, 2023
Classifications
1
FEI Numbers
4
Registration Numbers
4

Basic Information

Device Name
Stimulator, Neuromuscular, Lower Back Muscles, Totally Implanted For Pain Relief
Trade Name
Reactiv8 Implantable Neurostimulation System
PMA Number
P190021
Supplement Number
S003
Device Class
FDA Class 3
Product Code
QLK
Generic Name
Stimulator, neuromuscular, lower back muscles, totally implanted for pain relief
Medical Specialty
Unknown
Advisory Committee
Neurology
Decision
Approved
Decision Code
APPR
Decision Date
June 23, 2023
Date Received
January 13, 2023
Supplement Type
135 Review Track For 30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Approval for a change in manufacturing layout for the ReActiv8® Implantable Neurostimulation System to introduce improvements in the distribution of the Surface Mount Technology (SMT) manufacturing area and expand capacity to meet increasing volume of business.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
QLK Stimulator, Neuromuscular, Lower Back Muscles, Totally Implanted For Pain Relief